Medicamento contendo cilansetron para o tratamento de pacientes ibs masculinos não-obstipativos
"MEDICAMENTO CONTENDO CILANSETRON PARA O TRATAMENTO DE PACIENTES IBS MASCULINOS NãO-OBSTIPATIVOS". A presente invenção refere-se à utilização de Cilansetron para o tratamento de pacientes IBS masculinos não obstipativos. The invention relates to the use of cilansetron for treating non-obst...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | por |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | STEVEN DAVID CARAS WERNER CAUTREELS CLAUS RUDOLF STEINBORN ALBERTUS HERMANNUS DIRK PLEKKENPOL EGBERTUS HENDRIKUS EVERT BIESHEUVEL HEINZ GUENTER KRAUSE |
| description | "MEDICAMENTO CONTENDO CILANSETRON PARA O TRATAMENTO DE PACIENTES IBS MASCULINOS NãO-OBSTIPATIVOS". A presente invenção refere-se à utilização de Cilansetron para o tratamento de pacientes IBS masculinos não obstipativos.
The invention relates to the use of cilansetron for treating non-obstipated male IBS patients and also for treating patients of both sexes, who suffer from irritable bowel syndrome (IBS), by administering the pharmaceutical preparation three times a day. In said preparation, alosetron, azasetron, dolasetron, granisetron, indisetron, itasetron, lerisetron, ondansetron, ramosetron, tropisetron, and/or (R)-zacopride are used as 5HT3 receptor antagonists. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_BR0112690A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BR0112690A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_BR0112690A3</originalsourceid><addsrcrecordid>eNqFjDEKwkAQRdNYiHoG5wKBREGwVFFsbMQ-TnYnMJDMLJnRC3kUL-YW6a3-4_N48-J5o8gBBxJXCCpOEjNwj2LkowokHBEUfESftEj5DJyZDLg1GNDCq2dRA_l-tNTWnBM6v9WWxazD3mg17aJYX86P07WkpA1ZDpGQN8d7Vdeb3b46bP8bP35wPfs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Medicamento contendo cilansetron para o tratamento de pacientes ibs masculinos não-obstipativos</title><source>esp@cenet</source><creator>STEVEN DAVID CARAS ; WERNER CAUTREELS ; CLAUS RUDOLF STEINBORN ; ALBERTUS HERMANNUS DIRK PLEKKENPOL ; EGBERTUS HENDRIKUS EVERT BIESHEUVEL ; HEINZ GUENTER KRAUSE</creator><creatorcontrib>STEVEN DAVID CARAS ; WERNER CAUTREELS ; CLAUS RUDOLF STEINBORN ; ALBERTUS HERMANNUS DIRK PLEKKENPOL ; EGBERTUS HENDRIKUS EVERT BIESHEUVEL ; HEINZ GUENTER KRAUSE</creatorcontrib><description>"MEDICAMENTO CONTENDO CILANSETRON PARA O TRATAMENTO DE PACIENTES IBS MASCULINOS NãO-OBSTIPATIVOS". A presente invenção refere-se à utilização de Cilansetron para o tratamento de pacientes IBS masculinos não obstipativos.
The invention relates to the use of cilansetron for treating non-obstipated male IBS patients and also for treating patients of both sexes, who suffer from irritable bowel syndrome (IBS), by administering the pharmaceutical preparation three times a day. In said preparation, alosetron, azasetron, dolasetron, granisetron, indisetron, itasetron, lerisetron, ondansetron, ramosetron, tropisetron, and/or (R)-zacopride are used as 5HT3 receptor antagonists.</description><edition>7</edition><language>por</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2003</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030624&DB=EPODOC&CC=BR&NR=0112690A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030624&DB=EPODOC&CC=BR&NR=0112690A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>STEVEN DAVID CARAS</creatorcontrib><creatorcontrib>WERNER CAUTREELS</creatorcontrib><creatorcontrib>CLAUS RUDOLF STEINBORN</creatorcontrib><creatorcontrib>ALBERTUS HERMANNUS DIRK PLEKKENPOL</creatorcontrib><creatorcontrib>EGBERTUS HENDRIKUS EVERT BIESHEUVEL</creatorcontrib><creatorcontrib>HEINZ GUENTER KRAUSE</creatorcontrib><title>Medicamento contendo cilansetron para o tratamento de pacientes ibs masculinos não-obstipativos</title><description>"MEDICAMENTO CONTENDO CILANSETRON PARA O TRATAMENTO DE PACIENTES IBS MASCULINOS NãO-OBSTIPATIVOS". A presente invenção refere-se à utilização de Cilansetron para o tratamento de pacientes IBS masculinos não obstipativos.
The invention relates to the use of cilansetron for treating non-obstipated male IBS patients and also for treating patients of both sexes, who suffer from irritable bowel syndrome (IBS), by administering the pharmaceutical preparation three times a day. In said preparation, alosetron, azasetron, dolasetron, granisetron, indisetron, itasetron, lerisetron, ondansetron, ramosetron, tropisetron, and/or (R)-zacopride are used as 5HT3 receptor antagonists.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2003</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFjDEKwkAQRdNYiHoG5wKBREGwVFFsbMQ-TnYnMJDMLJnRC3kUL-YW6a3-4_N48-J5o8gBBxJXCCpOEjNwj2LkowokHBEUfESftEj5DJyZDLg1GNDCq2dRA_l-tNTWnBM6v9WWxazD3mg17aJYX86P07WkpA1ZDpGQN8d7Vdeb3b46bP8bP35wPfs</recordid><startdate>20030624</startdate><enddate>20030624</enddate><creator>STEVEN DAVID CARAS</creator><creator>WERNER CAUTREELS</creator><creator>CLAUS RUDOLF STEINBORN</creator><creator>ALBERTUS HERMANNUS DIRK PLEKKENPOL</creator><creator>EGBERTUS HENDRIKUS EVERT BIESHEUVEL</creator><creator>HEINZ GUENTER KRAUSE</creator><scope>EVB</scope></search><sort><creationdate>20030624</creationdate><title>Medicamento contendo cilansetron para o tratamento de pacientes ibs masculinos não-obstipativos</title><author>STEVEN DAVID CARAS ; WERNER CAUTREELS ; CLAUS RUDOLF STEINBORN ; ALBERTUS HERMANNUS DIRK PLEKKENPOL ; EGBERTUS HENDRIKUS EVERT BIESHEUVEL ; HEINZ GUENTER KRAUSE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_BR0112690A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>2003</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>STEVEN DAVID CARAS</creatorcontrib><creatorcontrib>WERNER CAUTREELS</creatorcontrib><creatorcontrib>CLAUS RUDOLF STEINBORN</creatorcontrib><creatorcontrib>ALBERTUS HERMANNUS DIRK PLEKKENPOL</creatorcontrib><creatorcontrib>EGBERTUS HENDRIKUS EVERT BIESHEUVEL</creatorcontrib><creatorcontrib>HEINZ GUENTER KRAUSE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>STEVEN DAVID CARAS</au><au>WERNER CAUTREELS</au><au>CLAUS RUDOLF STEINBORN</au><au>ALBERTUS HERMANNUS DIRK PLEKKENPOL</au><au>EGBERTUS HENDRIKUS EVERT BIESHEUVEL</au><au>HEINZ GUENTER KRAUSE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Medicamento contendo cilansetron para o tratamento de pacientes ibs masculinos não-obstipativos</title><date>2003-06-24</date><risdate>2003</risdate><abstract>"MEDICAMENTO CONTENDO CILANSETRON PARA O TRATAMENTO DE PACIENTES IBS MASCULINOS NãO-OBSTIPATIVOS". A presente invenção refere-se à utilização de Cilansetron para o tratamento de pacientes IBS masculinos não obstipativos.
The invention relates to the use of cilansetron for treating non-obstipated male IBS patients and also for treating patients of both sexes, who suffer from irritable bowel syndrome (IBS), by administering the pharmaceutical preparation three times a day. In said preparation, alosetron, azasetron, dolasetron, granisetron, indisetron, itasetron, lerisetron, ondansetron, ramosetron, tropisetron, and/or (R)-zacopride are used as 5HT3 receptor antagonists.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | por |
| recordid | cdi_epo_espacenet_BR0112690A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Medicamento contendo cilansetron para o tratamento de pacientes ibs masculinos não-obstipativos |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T14%3A48%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=STEVEN%20DAVID%20CARAS&rft.date=2003-06-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EBR0112690A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |